-
01
Ovarian Cancer Recurrence Warning
The value of recurrence monitoring lies in "preventing trouble before it happens." By providing early warning through CTCs in the blood, patients have the opportunity to intervene at the budding stage of recurrence, transforming a passive response into active management.
View
-
02
Drug Screening: Urothelial Carcinoma
Circulating tumor cells help overcome drug resistance challenges and provide references for treatment regimens.
View
-
03
Drug Screening: Mixed Germ Cell Tumor
Drug susceptibility test results can guide clinical medication, enable sustainable monitoring and evaluation of treatment efficacy, and allow for timely regimen adjustments.
View
-
04
Drug Screening: Non-Small Cell Lung Cancer
In cases where all clinically available drugs have become ineffective, CTCs can be cultured in vitro for extensive drug screening, offering hope of identifying a sensitive drug.
View
-
05
Multi-cancer Auxiliary Diagnosis
Circulating tumor cell (CTC) detection, with its advantages of being non-invasive, real-time, and repeatable, is becoming an important tool for auxiliary diagnosis.
View
-
06
Efficacy Monitoring: Breast Cancer
CTC testing helps assess MRD
View
-
07
Efficacy Monitoring: Ovarian Cancer
CTC testing helps assess MRD
View
-
08
Efficacy Monitoring: Cervical Cancer
CTC testing helps assess MRD
View